BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30547197)

  • 1. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
    Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
    World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours.
    Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
    Eur J Cancer; 2016 Dec; 69():151-157. PubMed ID: 27821318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
    Terbuch A; Walser G; Stotz M; Gerger A; Posch F; Bauernhofer T
    Clin Genitourin Cancer; 2023 Feb; 21(1):24-31. PubMed ID: 36400695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor.
    Nitta S; Kawai K; Kimura T; Kawahara T; Kandori S; Hoshi A; Kojima T; Nishiyama H
    Jpn J Clin Oncol; 2020 Mar; 50(3):338-343. PubMed ID: 32037439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
    Heidegger I; Porres D; Veek N; Heidenreich A; Pfister D
    Urol Int; 2017; 99(1):104-109. PubMed ID: 28514776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy.
    Honecker F; Koychev D; Luhmann AD; Langer F; Dieckmann KP; Bokemeyer C; Oechsle K
    Onkologie; 2013; 36(11):663-8. PubMed ID: 24192771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
    Fankhauser CD; Tran B; Pedregal M; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Del Muro XG; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL; Sweeney CJ; Connors JM
    Eur Urol Focus; 2021 Sep; 7(5):1130-1136. PubMed ID: 33032968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
    Lee YG; Lee E; Kim I; Lee KW; Kim TM; Lee SH; Kim DW; Heo DS
    Cancer Res Treat; 2015 Oct; 47(4):670-5. PubMed ID: 25672586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
    Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
    BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thromboembolic complications during cisplatin-containing chemotherapy for testicular cancer: a problem in the short and possibly also the long term].
    Nuver J; Gietema JA
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):428-30. PubMed ID: 12666510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy.
    Bamias A; Tzannis K; Dimitriadis I; Tsironis G; Papatheorodidi AM; Tsiara A; Fragkoulis C; Xirokosta A; Barbarousi D; Papadopoulos G; Zakopoulou R; Varkarakis I; Mitsogiannis I; Adamakis I; Alamanis C; Stravodimos K; Papatsoris AG; Dellis AE; Drivalos A; Ntoumas K; Matsouka H; Halvatsiotis P; Raptis A; Gerotziafas GT; Dimopoulos MA
    Clin Genitourin Cancer; 2020 Aug; 18(4):e457-e472. PubMed ID: 32007440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
    Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
    Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.
    Weijl NI; Rutten MF; Zwinderman AH; Keizer HJ; Nooy MA; Rosendaal FR; Cleton FJ; Osanto S
    J Clin Oncol; 2000 May; 18(10):2169-78. PubMed ID: 10811682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy.
    Solari L; Krönig M; Ihorst G; Drognitz K; Heinz J; Jilg CA; Schultze-Seemann W; Engelhardt M; Waller CF
    Urol Int; 2016; 96(4):399-405. PubMed ID: 27074038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.
    Khanna A; Reece-Smith AM; Cunnell M; Madhusudan S; Thomas A; Bowrey DJ; Parsons SL
    Dis Esophagus; 2014 Apr; 27(3):242-7. PubMed ID: 23651074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas.
    Mitchell SY; Lingard EA; Kesteven P; McCaskie AW; Gerrand CH
    J Bone Joint Surg Am; 2007 Nov; 89(11):2433-9. PubMed ID: 17974886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal basilar artery thrombosis after chemotherapy for testicular cancer.
    Doehn C; Büttner H; Fornara P; Jocham D
    Urol Int; 2000; 65(1):43-5. PubMed ID: 10965301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral Venous Sinus Thrombosis Following Cisplatin-Based Chemotherapy for Testicular Tumor].
    Ishihara M; Satoh K; Hanaoka M; Matsuzaki K; Matsuda T; Miyake H; Niki H
    No Shinkei Geka; 2017 May; 45(5):417-422. PubMed ID: 28490684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the
    Bloomquist K; Andersen C; Munck S; Lillelund C; Lauritsen J
    Acta Oncol; 2023 Jun; 62(6):666-672. PubMed ID: 37450654
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
    Mellema WW; van der Hoek D; Postmus PE; Smit EF
    Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.